| Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks J Khan, JS Wei, M Ringner, LH Saal, M Ladanyi, F Westermann, ... Nature medicine 7 (6), 673-679, 2001 | 3543 | 2001 |
| The genetic landscape of high-risk neuroblastoma TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ... Nature genetics 45 (3), 279-284, 2013 | 1172 | 2013 |
| Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 686 | 2014 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 535 | 2015 |
| The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, ... PLoS genetics 10 (7), e1004475, 2014 | 418 | 2014 |
| Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models JGT Vi, AT Cheuk, PS Tsang, JY Chung, YK Song, K Desai, Y Yu, ... The Journal of clinical investigation 119 (11), 3395-3407, 2009 | 355 | 2009 |
| The MYCN oncogene is a direct target of miR-34a JS Wei, YK Song, S Durinck, QR Chen, ATC Cheuk, P Tsang, Q Zhang, ... Oncogene 27 (39), 5204-5213, 2008 | 354 | 2008 |
| Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism DA Oldridge, AC Wood, N Weichert-Leahey, I Crimmins, R Sussman, ... Nature 528 (7582), 418-421, 2015 | 300 | 2015 |
| Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma JS Wei, BT Greer, F Westermann, SM Steinberg, CG Son, QR Chen, ... Cancer research 64 (19), 6883-6891, 2004 | 257 | 2004 |
| PAX3–FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability BE Gryder, ME Yohe, HC Chou, X Zhang, J Marques, M Wachtel, ... Cancer Discovery 7 (8), 884-899, 2017 | 250 | 2017 |
| Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis L Mariani, C Beaudry, WS McDonough, DB Hoelzinger, T Demuth, ... Journal of neuro-oncology 53, 161-176, 2001 | 225 | 2001 |
| EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR C Wang, Z Liu, CW Woo, Z Li, L Wang, JS Wei, VE Marquez, SE Bates, ... Cancer research 72 (1), 315-324, 2012 | 211 | 2012 |
| Apparatus for microarray binding sensors having biological probe materials using carbon nanotube transistors RDR Gomez, J Khan, H Pandana, K Aschenbach, M Fuhrer, JS Wei US Patent 8,017,938, 2011 | 209 | 2011 |
| Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity J Lu, TE Landerholm, JS Wei, XR Dong, SP Wu, X Liu, K Nagata, ... Developmental biology 240 (2), 404-418, 2001 | 196 | 2001 |
| Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ... Cancer cell 32 (3), 295-309. e12, 2017 | 167 | 2017 |
| Database of mRNA gene expression profiles of multiple human organs CG Son, S Bilke, S Davis, BT Greer, JS Wei, CC Whiteford, QR Chen, ... Genome research 15 (3), 443-450, 2005 | 156 | 2005 |
| CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ... Cancer research 75 (15), 3155-3166, 2015 | 155 | 2015 |
| Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers RJ Orentas, JJ Yang, X Wen, JS Wei, CL Mackall, J Khan Frontiers in oncology 2, 194, 2012 | 152 | 2012 |
| Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy R Hassan, B Morrow, A Thomas, T Walsh, MK Lee, S Gulsuner, ... Proceedings of the National Academy of Sciences 116 (18), 9008-9013, 2019 | 133 | 2019 |
| Cross-cohort analysis identifies a TEAD4–MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma P Rajbhandari, G Lopez, C Capdevila, B Salvatori, J Yu, ... Cancer discovery 8 (5), 582-599, 2018 | 128 | 2018 |
Javed KhanDeputy Branch Chief Genetics Branch, Senior Investigator, Center for Cancer Research, NCI, NIHVerified email at mail.nih.gov
